Evidence map›Paper›PMID 35420710›Full record

ArticleAlcoholism, clinical and experimental research2022

Using machine learning to predict heavy drinking during outpatient alcohol treatment.

Walter Roberts, Yize Zhao, Terril Verplaetse, Kelly E Moore, MacKenzie R Peltier, Catherine Burke, Yasmin Zakiniaeiz, Sherry McKee

Open access · greenAbstract read
In one paragraph

Article in Alcoholism, clinical and experimental research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Walter RobertsDepartment of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.ORCID 0000-0001-6817-884X
Yize ZhaoDepartment of Biostatistics, Yale University School of Public Health, New Haven, Connecticut, USA.
Terril VerplaetseDepartment of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.ORCID 0000-0002-2531-6656
Kelly E MooreDepartment of Psychology, East Tennessee State University, Johnson City, Tennessee, USA.
MacKenzie R PeltierDepartment of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.ORCID 0000-0002-8211-4815
Catherine BurkeDepartment of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.
Yasmin ZakiniaeizDepartment of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.
Sherry McKeeDepartment of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.
Yale University · USEast Tennessee State University · US

Funding

Yale-SCORE Resource Support CoreU54AA027989 · NIAAA · YALE UNIVERSITY · PI Ralitza Gueorguieva · 2020 to 2026
$13.0M
PET imaging of Naltrexone Occupancy of Kappa Receptors in Heavy DrinkersR01AA021818 · NIAAA · YALE UNIVERSITY · PI KRISHNAN-SARIN, SUCHITRA, MORRIS, EVAN D · 2013 to 2019
$3.4M
Novel integrative imaging genetics analysis for Alzheimer's disease riskand progressionRF1AG068191 · NIA · YALE UNIVERSITY · PI ZHAO, YIZE · 2021 to 2021
$1.9M
Novel integrative imaging genetics analysis for Alzheimer's disease riskand progressionR01AG068191 · NIA · YALE UNIVERSITY · PI ZHAO, YIZE · 2024 to 2025
$1.2M
Behavioral and Neurochemical Mechanisms Underlying Stress-Precipitated DrinkingK01AA025670 · NIAAA · YALE UNIVERSITY · PI VERPLAETSE, TERRIL L · 2018 to 2023
$882k
Developing a mobile alcohol biosensor platform for use in medication testing researchK23AA026890 · NIAAA · YALE UNIVERSITY · PI ROBERTS, WALTER MCRAINEY · 2019 to 2023
$827k
Does endotoxin administration increase alcohol consumption in individuals with AUD?R03AA028361 · NIAAA · YALE UNIVERSITY · PI VERPLAETSE, TERRIL L · 2021 to 2022
$168k
NIAAA NIH HHS K01 AA025670NIAAA NIH HHS K23 AA026890NIAAA NIH HHS R01 AA021818NIAAA NIH HHS R03 AA028361NIAAA NIH HHS U54 AA027989NIA NIH HHS R01 AG068191NIA NIH HHS RF1 AG068191
6 · The paper itself

Abstract

backgroundAccurate clinical prediction supports the effective treatment of alcohol use disorder (AUD) and other psychiatric disorders. Traditional statistical techniques have identified patient characteristics associated with treatment outcomes. However, less work has focused on systematically leveraging these associations to create optimal predictive models. The current study demonstrates how machine learning can be used to predict clinical outcomes in people completing outpatient AUD treatment.

methodWe used data from the COMBINE multisite clinical trial (n = 1383) to develop and test predictive models. We identified three priority prediction targets, including (1) heavy drinking during the first month of treatment, (2) heavy drinking during the last month of treatment, and (3) heavy drinking between weekly/bi-weekly sessions. Models were generated using the random forest algorithm. We used "leave sites out" partitioning to externally validate the models in trial sites that were not included in the model training. Stratified model development was used to test for sex differences in the relative importance of predictive features.

resultsModels predicting heavy alcohol use during the first and last months of treatment showed internal cross-validation area under the curve (AUC) scores ranging from 0.67 to 0.74. AUC was comparable in the external validation using data from held-out sites (AUC range = 0.69 to 0.72). The model predicting between-session heavy drinking showed strong classification accuracy in internal cross-validation (AUC = 0.89) and external test samples (AUC range = 0.80 to 0.87). Stratified analyses showed substantial sex differences in optimal feature sets.

conclusionMachine learning techniques can predict alcohol treatment outcomes using routinely collected clinical data. This technique has the potential to greatly improve clinical prediction accuracy without requiring expensive or invasive assessment methods. More research is needed to understand how best to deploy these models.

Indexed as

AlcoholismOutpatientsAlgorithmsEthanolFemaleHumansMachine LearningMaleTreatment OutcomeEthanolalcohol use disorderCOMBINEmachine learningpredictiontreatment outcomes

Identifiers

PMID35420710
PMCPMC9180421
OpenAlexW4224095018

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.